Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - FLYNN JAMES E
Last Updated 
30-Mar-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

FLYNN JAMES E: Declared Holdings
Company/RelationshipReportedShares  Ownership
Avalanche Biotechnologies, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AAVL
(historical quotes, profile, other insiders)
5-Aug-142,197,679  Indirect
Auspex Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ASPX
(historical quotes, profile, other insiders)
28-Jan-154,449,103  Indirect
Auxilium Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:AUXL
(historical quotes, other insiders)
29-Jan-150  Indirect
AxoGen, Inc.
Beneficial Owner (10% or more)
NasdaqCM:AXGN
(historical quotes, profile, other insiders)
10-Feb-153,870,824  Indirect
CAS Medical Systems, Inc.
Beneficial Owner (10% or more)
NasdaqCM:CASM
(historical quotes, profile, other insiders)
1-Jan-153,200,000  Indirect
Dicerna Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DRNA
(historical quotes, profile, other insiders)
25-Nov-141,774,662  Indirect
eHealth, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EHTH
(historical quotes, profile, other insiders)
6-Mar-153,264,588  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,591,546  Indirect
Invitae Corporation Common Stoc
Beneficial Owner (10% or more)
NYSE:NVTA
(historical quotes, profile, other insiders)
18-Feb-15341,666  Indirect
Proteon Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:PRTO
(historical quotes, profile, other insiders)
27-Oct-141,255,107  Indirect
TriVascular Technologies, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TRIV
(historical quotes, profile, other insiders)
22-Apr-141,697,669  Indirect
Vanda Pharmaceuticals Inc.
Beneficial Owner (10% or more)
NasdaqGM:VNDA
(historical quotes, profile, other insiders)
23-Dec-144,139,787  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
6-Mar-15 *30,103EHTH Purchase at $9.52 per share.
(Cost of $286,580)
18-Feb-15 *175,000NVTA Purchase at $16 per share.
(Cost of $2,800,000)
18-Feb-15 *166,666NVTA Acquisition (Non Open Market)
10-Feb-15 *3,870,824AXGN Statement of Ownership
29-Jan-15 *6,267,382AUXL Disposition (Non Open Market)
28-Jan-15 *1,500,000ASPX Purchase at $56.50 per share.
(Cost of $84,750,000)
14-Jan-15 *1,000,000EHTH Purchase at $19.84 - $20.45 per share.
(Cost of about $20,145,000)
1-Jan-15 *1,443,200CASM Sale at $1.65 per share.
(Proceeds of $2,381,280)
1-Jan-15 *1,443,200CASM Purchase at $1.65 per share.
(Cost of $2,381,280)
23-Dec-14 *3,977,773VNDA Statement of Ownership
23-Dec-14 *162,014VNDA Purchase at $14.23 - $14.5 per share.
(Cost of about $2,327,000)
18-Dec-14 *2,949,103ASPX Statement of Ownership
25-Nov-14 *121,965DRNA Sale at $11.50 per share.
(Proceeds of $1,402,597)
24-Nov-14 *100,000DRNA Sale at $11.54 - $11.55 per share.
(Proceeds of about $1,155,000)
21-Nov-14 *100,000DRNA Sale at $11 per share.
(Proceeds of $1,100,000)
7-Nov-14 *214,164DRNA Sale at $9 - $9.33 per share.
(Proceeds of about $1,963,000)
27-Oct-14 *563,394PRTO Acquisition (Non Open Market)
27-Oct-14 *691,713PRTO Purchase at $10 per share.
(Cost of $6,917,130)
15-Oct-14 *51,449DRNA Sale at $10.01 per share.
(Proceeds of $515,004)
14-Oct-14 *36,115DRNA Sale at $11.02 per share.
(Proceeds of $397,987)
10-Oct-14 *30,214DRNA Sale at $12 - $12.14 per share.
(Proceeds of about $365,000)
7-Aug-14 *3,131EHTH Purchase at $21.05 per share.
(Cost of $65,907)
6-Aug-14 *501,890LOXO Acquisition (Non Open Market)
6-Aug-14 *1,089,656LOXO Purchase at $13 - $13.05 per share.
(Cost of about $14,193,000)
5-Aug-14 *863,212AAVL Acquisition (Non Open Market)
5-Aug-14 *3,770EHTH Purchase at $20.99 per share.
(Cost of $79,132)
5-Aug-14 *1,334,467AAVL Purchase at $17 - $27.54 per share.
4-Aug-14 *155,470EHTH Purchase at $20.40 - $20.75 per share.
(Cost of about $3,199,000)
1-Aug-14 *170,300EHTH Purchase at $19.04 - $19.4 per share.
(Cost of about $3,273,000)
1-Aug-14 *1,931,917EHTH Statement of Ownership
6-Jun-14 *6,267,382AUXL Statement of Ownership
22-Apr-14 *1,065,000TRIV Purchase at $11.97 - $12.29 per share.
(Cost of about $12,918,000)
22-Apr-14 *632,669TRIV Acquisition (Non Open Market)
10-Feb-14 *700,000ASPX Purchase at $12 per share.
(Cost of $8,400,000)
10-Feb-14 *1,288,990ASPX Acquisition (Non Open Market)
4-Feb-14 *1,000,000DRNA Purchase at $15 per share.
(Cost of $15,000,000)
4-Feb-14 *1,428,569DRNA Acquisition (Non Open Market)
17-Jul-13 *3,200,000CASM Statement of Ownership
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?